Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire.
- R. Hirschfeld, J. Williams, J. Zajecka
- Psychology, MedicineAmerican Journal of Psychiatry
- 1 November 2000
The Mood Disorder Questionnaire is a useful screening instrument for bipolar spectrum disorder in a psychiatric outpatient population and has good sensitivity and very good specificity.
Compulsive buying: a report of 20 cases.
- S. McElroy, P. Keck, H. Pope, J. M. Smith, S. Strakowski
- Medicine, PsychologyJournal of Clinical Psychiatry
Compulsive buying may cause significant psychological, interpersonal, and financial difficulties; may co-occur with other psychiatric disorders; may be treatable; and should be further studied as a mental disorder in its own right.
A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
Quetiapine monotherapy is efficacious and well tolerated for the treatment of bipolar depression and demonstrated statistically significant improvement in Montgomery-Asberg Depression Rating Scale total scores compared with placebo from week 1 onward.
Screening for bipolar disorder in the community.
The positive MDQ screen rate of 3.7% suggests that nearly 4% of American adults may suffer from bipolar I and II disorders, and young adults and individuals with lower income are at greater risk for this largely underdiagnosed disorder.
Psychiatric features of individuals with problematic internet use.
Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder.
Comorbid lifetime and current axis I disorders in 288 patients with bipolar disorder and the relationships of these comorbid disorders to selected demographic and historical illness variables showed associations with earlier age at onset of affective symptoms and syndromal bipolar disorder.
Validity of the mood disorder questionnaire: a general population study.
The Mood Disorder Questionnaire is a useful screening instrument for bipolar I and II disorders in the community and its operating characteristics in the general population differ substantially from its characteristics in outpatient psychiatric settings.
Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry.
The preponderance of epidemiologic and tissue compositional studies supports a protective effect of omega-3 EFA intake, particularly eicosapentaenoic acid (EPA) and docosahexaenoic Acid (DHA), in mood disorders.
Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network.
It is indicated that a history of suicide attempts is associated with a more difficult course of bipolar disorder and the occurrence of more psychosocial stressors at many different time domains.